MYC and cancer: Notwithstanding the fact that the expression levels of genes involved in the Wnt pathway and EMT process were not influenced, cancer cells surviving the in vivo combinatorial treatment showed a markedly increased expression of MYC levels, regardless of the mutational status (Figure 4A).